NCT06097442View on ClinicalTrials.gov

Effect of Apollo Wearable on Long COVID-19 Symptoms.

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Post-acute Sequelae of SARS-COV-2 Infection
Trial Locations (1)

15219

RECRUITING

The Board of Medicine, Pittsburgh

Sponsors

Collaborators (1)

Apollo Neuroscience, Inc.
All Listed Sponsors
collaborator

Apollo Neuroscience, Inc.

INDUSTRY

lead

The Board of Medicine

OTHER